{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:06:43Z","timestamp":1768014403308,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synthetic cathinones appeared on the market in the 2000s as new psychoactive substances and gained significant prevalence among drug abusers. Cathinones produce psychostimulant and empathogenic effects by enhancing dopaminergic, noradrenergic, and serotoninergic neurotransmission in the brain, and those which potently and selectively enhance dopaminergic transmission are considered to have higher abuse potential. The present study examines the behavioral effects related to psychostimulant properties, abuse potential, and addiction in DBA\/2J mice of two cathinones with different profile of action on monoamine system, 4-chloromethcathinone (4-CMC), and 4-methoxy-pyrrolidinopentiophenone (4-MeO-PVP). 4-CMC and 4-MeO-PVP increase spontaneous locomotor activity after acute treatment and produce behavioral sensitization after 7-day intermittent treatment, which is a common feature of drugs of abuse. 4-MeO-PVP, but not 4-CMC, produces conditioned place preference after 4 days, indicating its rewarding properties. Finally, the ability of 4-CMC and 4-MeO-PVP to induce withdrawal symptoms after discontinuation from 14-day treatment was assessed using a battery of tests for behavioral markers of depression in mice: a tail suspension test, a forced swim test, measuring despair, and a sucrose preference test, measuring anhedonia. None of the three tests revealed increased depressive symptoms. Moreover, neither spontaneous locomotor activity nor motor performance on a rotarod was impaired after 14-day treatment with the tested compounds. These results indicate that 14-day treatment of mice with 4-CMC or 4-MeO-PVP does not induce significant withdrawal symptoms after cessation, nor significant impairment of dopaminergic circuitry resulting in motor impairment. The current study shows that 4-CMC and 4-MeO-PVP produce abuse-related behavioral changes in mice, which are more pronounced after more dopamine-selective 4-MeO-PVP.<\/jats:p>","DOI":"10.1007\/s12640-021-00329-x","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:39:42Z","timestamp":1610354382000},"page":"575-587","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Behavioral Effects of 4-CMC and 4-MeO-PVP in DBA\/2J Mice After Acute and Intermittent Administration and Following Withdrawal from Intermittent 14-Day Treatment"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9903-7206","authenticated-orcid":false,"given":"Jakub","family":"Wojcieszak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kuczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta B.","family":"Zawilska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,11]]},"reference":[{"key":"329_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","volume":"71","author":"SM Aarde","year":"2013","unstructured":"Aarde SM, Huang PK, Creehan KM, Dickerson TJ, Taffe MA (2013) The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats. Neuropharmacology 71:130\u2013140. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.04.003","journal-title":"Neuropharmacology"},{"issue":"1","key":"329_CR2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-019-00020-2","volume":"36","author":"SA Allen","year":"2019","unstructured":"Allen SA, Tran LH, Oakes HV, Brown RW, Pond BB (2019) Dopaminergic effects of major bath salt constituents 3,4-methylenedioxypyrovalerone (MDPV), mephedrone, and methylone are enhanced following co-exposure. Neurotox Res 36(1):132\u2013143. https:\/\/doi.org\/10.1007\/s12640-019-00020-2","journal-title":"Neurotox Res"},{"issue":"3","key":"329_CR3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/0269881118822151","volume":"33","author":"LA Atehortua-Martinez","year":"2019","unstructured":"Atehortua-Martinez LA, Masniere C, Campolongo P, Chasseigneaux S, Callebert J et al (2019) Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat. J Psychopharmacol 33(3):392\u2013405. https:\/\/doi.org\/10.1177\/0269881118822151","journal-title":"J Psychopharmacol"},{"key":"329_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.drugalcdep.2016.05.001","volume":"164","author":"MD Berquist 2nd","year":"2016","unstructured":"Berquist MD 2nd, Traxler HK, Mahler AM, Baker LE (2016) Sensitization to the locomotor stimulant effects of \u201cbath salt\u201d constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats. Drug Alcohol Depend 164:128\u2013134. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.05.001","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"329_CR5","first-page":"343","volume":"52","author":"T Bia\u0142as","year":"2016","unstructured":"Bia\u0142as T, Barczuk-Martuszewska K, Posobkiewicz M, Kucharska I, Klimberg A (2017) New drugs in Poland \u2013 latest trends according to State Sanitary Inspection data of 2015\u20132016. Hygeia Public Health 52(4):343\u2013351","journal-title":"Hygeia Public Health"},{"issue":"10","key":"329_CR6","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML et al (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172(10):2433\u20132444. https:\/\/doi.org\/10.1111\/bph.13030","journal-title":"Br J Pharmacol"},{"issue":"4","key":"329_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1601-183X.2011.00682.x","volume":"10","author":"A Can","year":"2011","unstructured":"Can A, Blackwell RA, Piantadosi SC, Dao DT, O\u2019Donnell KC et al (2011) Antidepressant-like responses to lithium in genetically diverse mouse strains. Genes Brain Behav 10(4):434\u2013443. https:\/\/doi.org\/10.1111\/j.1601-183X.2011.00682.x","journal-title":"Genes Brain Behav"},{"key":"329_CR8","doi-asserted-by":"publisher","first-page":"e3769","DOI":"10.3791\/3769","volume":"59","author":"A Can","year":"2012","unstructured":"Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S et al (2012) The tail suspension test. J Vis Exp 59:e3769. https:\/\/doi.org\/10.3791\/3769","journal-title":"J Vis Exp"},{"key":"329_CR9","doi-asserted-by":"publisher","unstructured":"Castagn\u00e9 V, Moser P, Roux S, Porsolt RD (2011) Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci 55(1):Chapter 8. https:\/\/doi.org\/10.1002\/0471142301.ns0810as55","DOI":"10.1002\/0471142301.ns0810as55"},{"issue":"5","key":"329_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00213-017-4526-8","volume":"234","author":"JH Cheong","year":"2017","unstructured":"Cheong JH, Choi MJ, Jang CG, Lee YS, Lee S et al (2017) Behavioral evidence for the abuse potential of the novel synthetic cathinone alpha-pyrrolidinopentiothiophenone (PVT) in rodents. Psychopharmacology (Berl) 234(5):857\u2013867. https:\/\/doi.org\/10.1007\/s00213-017-4526-8","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"329_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0006-3223(02)01730-4","volume":"54","author":"JF Cryan","year":"2003","unstructured":"Cryan JF, Hoyer D, Markou A (2003) Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol Psychiatry 54(1):49\u201358. https:\/\/doi.org\/10.1016\/S0006-3223(02)01730-4","journal-title":"Biol Psychiatry"},{"issue":"1","key":"329_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s002130051090","volume":"146","author":"CL Cunningham","year":"1999","unstructured":"Cunningham CL, Dickinson SD, Grahame NJ, Okorn DM, McMullin CS (1999) Genetic differences in cocaine-induced conditioned place preference in mice depend on conditioning trial duration. Psychopharmacology (Berl) 146(1):73\u201380. https:\/\/doi.org\/10.1007\/s002130051090","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"329_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.pbb.2012.10.006","volume":"103","author":"B den Hollander","year":"2013","unstructured":"den Hollander B, Rozov S, Linden AM, Uusi-Oukari M, Ojanper\u00e4 I et al (2013) Long-term cognitive and neurochemical effects of \u201cbath salt\u201d designer drugs methylone and mephedrone. Pharmacol Biochem Behav 103(3):501\u2013509. https:\/\/doi.org\/10.1016\/j.pbb.2012.10.006","journal-title":"Pharmacol Biochem Behav"},{"key":"329_CR14","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neuropharm.2018.10.005","volume":"144","author":"L Duart-Castells","year":"2019","unstructured":"Duart-Castells L, L\u00f3pez-Arnau R, Buenrostro-J\u00e1uregui M, Mu\u00f1oz-Villegas P, Valverde O (2019) Neuroadaptive changes and behavioral effects after a sensitization regime of MDPV. Neuropharmacology 144:271\u2013281. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.10.005","journal-title":"Neuropharmacology"},{"key":"329_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11419-015-0287-4","volume":"34","author":"KN Ellefsen","year":"2016","unstructured":"Ellefsen KN, Wohlfarth A, Swortwood MJ, Diao X, Concheiro M et al (2016) 4-Methoxy-\u03b1-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicol 34:61\u201375. https:\/\/doi.org\/10.1007\/s11419-015-0287-4","journal-title":"Forensic Toxicol"},{"key":"329_CR16","unstructured":"EMCDDA (2016), Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (\u03b1-pyrrolidinovalerophenone, \u03b1-PVP) in the framework of the Council Decision on new psychoactive substances, Risk Assessments.\u00a0https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2934\/TDAK16001ENN.pdf.Accessed 10 Dec 2020"},{"key":"329_CR17","unstructured":"EMCDDA (2018) European drug report. Trends and developments.\u00a0https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/8585\/20181816_TDAT18001ENN_PDF.pdf.Accessed 10 Dec 2020"},{"key":"329_CR18","unstructured":"EMCDDA (2019) European drug report. Trends and developments.http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/11364\/20191724_TDAT19001ENN_PDF.pdf.Accessed 12 Jun 2020"},{"issue":"12","key":"329_CR19","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bcp.2013.04.004","volume":"85","author":"AJ Eshleman","year":"2013","unstructured":"Eshleman AJ, Wolfrum KM, Hatfield MG, Johnson RA, Murphy KV et al (2013) Substituted methcathinones differ in transporter and receptor interactions. Biochem Pharmacol 85(12):1803\u20131815. https:\/\/doi.org\/10.1016\/j.bcp.2013.04.004","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"329_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349","volume":"360","author":"AJ Eshleman","year":"2017","unstructured":"Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Swanson T et al (2017) Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. J Pharmacol Exp Ther 360(1):33\u201347. https:\/\/doi.org\/10.1124\/jpet.116.236349","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"329_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/jpet.115.223586","volume":"354","author":"MB Gatch","year":"2015","unstructured":"Gatch MB, Dolan SB, Forster MJ (2015) Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives. J Pharmacol Exp Ther 354(2):103\u2013110. https:\/\/doi.org\/10.1124\/jpet.115.223586","journal-title":"J Pharmacol Exp Ther"},{"key":"329_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.drugalcdep.2019.02.016","volume":"199","author":"MB Gatch","year":"2019","unstructured":"Gatch MB, Dolan SB, Forster MJ (2019) Locomotor activity and discriminative stimulus effects of five novel synthetic cathinone analogs in mice and rats. Drug Alcohol Depend 199:50\u201358. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.016","journal-title":"Drug Alcohol Depend"},{"key":"329_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neuropharm.2016.04.014","volume":"108","author":"RA Gregg","year":"2016","unstructured":"Gregg RA, Hicks C, Nayak SU, Tallarida CS, Nucero P et al (2016) Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology 108:111\u2013119. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.04.014","journal-title":"Neuropharmacology"},{"issue":"2","key":"329_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.drugalcdep.2013.06.014","volume":"133","author":"RA Gregg","year":"2013","unstructured":"Gregg RA, Tallarida CS, Reitz A, McCurdy C, Rawls SM (2013) Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. Drug Alcohol Depend 133(2):746\u2013750. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.06.014","journal-title":"Drug Alcohol Depend"},{"key":"329_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.neuropharm.2014.01.015","volume":"87","author":"L Iversen","year":"2014","unstructured":"Iversen L, White M, Treble R (2014) Designer psychostimulants: pharmacology and differences. Neuropharmacology 87:59\u201365. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.015","journal-title":"Neuropharmacology"},{"issue":"5","key":"329_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bcpt.12253","volume":"115","author":"L Karlsson","year":"2014","unstructured":"Karlsson L, Andersson M, Kronstrand R, Kugelberg FC (2014) Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice. Basic Clin Pharmacol Toxicol 115(5):411\u2013416. https:\/\/doi.org\/10.1111\/bcpt.12253","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"329_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.drugalcdep.2014.11.002","volume":"146","author":"HE King","year":"2015","unstructured":"King HE, Wetzell B, Rice KC, Riley AL (2015) An assessment of MDPV-induced place preference in adult Sprague-Dawley rats. Drug Alcohol Depend 146:116\u2013119. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.002","journal-title":"Drug Alcohol Depend"},{"issue":"Pt A","key":"329_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuropharm.2017.10.019","volume":"134","author":"RJ Kohler","year":"2018","unstructured":"Kohler RJ, Perrine SA, Baker LE (2018) Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines. Neuropharmacology 134(Pt A):22\u201327. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.019","journal-title":"Neuropharmacology"},{"key":"329_CR29","doi-asserted-by":"publisher","first-page":"w14043","DOI":"10.4414\/smw.2015.14043","volume":"145","author":"M Liechti","year":"2015","unstructured":"Liechti M (2015) Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling. Swiss Med Wkly 145:w14043. https:\/\/doi.org\/10.4414\/smw.2015.14043","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"329_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155(3):315\u2013322. https:\/\/doi.org\/10.1007\/s002130100694","journal-title":"Psychopharmacology (Berl)"},{"key":"329_CR31","doi-asserted-by":"publisher","unstructured":"Mac\u00fachov\u00e1 E, \u0160lamberov\u00e1 R (2017) Does prenatal methamphetamine exposure induce sensitization to drugs in adulthood? Physiol Res 66(Suppl 4):S457\u2013S467.\u00a0https:\/\/doi.org\/10.33549\/physiolres.933803","DOI":"10.33549\/physiolres.933803"},{"issue":"6","key":"329_CR32","doi-asserted-by":"publisher","first-page":"e99002","DOI":"10.1371\/journal.pone.0099002","volume":"9","author":"J Mart\u00ednez-Clemente","year":"2014","unstructured":"Mart\u00ednez-Clemente J, L\u00f3pez-Arnau R, Abad S, Pubill D, Escubedo E et al (2014) Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One 9(6):e99002. https:\/\/doi.org\/10.1371\/journal.pone.0099002","journal-title":"PLoS One"},{"key":"329_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.drugalcdep.2018.01.013","volume":"186","author":"CF Oliver","year":"2018","unstructured":"Oliver CF, Simmons SJ, Nayak SU, Smith GR, Reitz AB et al (2018) Chemokines and \u201cbath salts\u201d: CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug Alcohol Depend 186:75\u201379. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.01.013","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"329_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00213-005-2259-6","volume":"181","author":"C Orsini","year":"2005","unstructured":"Orsini C, Bonito-Oliva A, Conversi D, Cabib S (2005) Susceptibility to conditioned place preference induced by addictive drugs in mice of the C57BL\/6 and DBA\/2 inbred strains. Psychopharmacology (Berl) 181(2):327\u2013336. https:\/\/doi.org\/10.1007\/s00213-005-2259-6","journal-title":"Psychopharmacology (Berl)"},{"key":"329_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.drugalcdep.2017.04.024","volume":"178","author":"HL Philogene-Khalid","year":"2017","unstructured":"Philogene-Khalid HL, Hicks C, Reitz AB, Liu-Chen LY, Rawls SM (2017) Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats. Drug Alcohol Depend 178:119\u2013125. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.04.024","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"329_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008877-200302000-00001","volume":"14","author":"H Russig","year":"2003","unstructured":"Russig H, Pezze MA, Nanz-Bahr NI, Pryce CR, Feldon J et al (2003) Amphetamine withdrawal does not produce a depressive-like state in rats as measured by three behavioral tests. Behav Pharmacol 14(1):1\u201318. https:\/\/doi.org\/10.1097\/00008877-200302000-00001","journal-title":"Behav Pharmacol"},{"key":"329_CR37","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1016\/j.forsciint.2014.09.007","volume":"244","author":"M Taschwer","year":"2014","unstructured":"Taschwer M, Wei\u00df JA, Kunert O, Schmid MG (2014) Analysis and characterization of the novel psychoactive drug 4-chloromethcathinone (clephedrone). Forensic Sci Int 244:e56\u2013e59. https:\/\/doi.org\/10.1016\/j.forsciint.2014.09.007","journal-title":"Forensic Sci Int"},{"key":"329_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11419-013-0194-5","volume":"32","author":"N Uchiyama","year":"2013","unstructured":"Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y (2013) Identification of two new-type designer drugs, piperazine derivative MT-45 (I-C6) and synthetic peptide Noopept (GVS-111), with synthetic cannabinoid A-834735, cathinone derivative 4-methoxy-\u03b1-PVP, and phenethylamine derivative 4-methylbuphedrine from illegal products. Forensic Toxicol 32:9\u201318. https:\/\/doi.org\/10.1007\/s11419-013-0194-5","journal-title":"Forensic Toxicol"},{"issue":"4","key":"329_CR39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1601-183X.2004.00106.x","volume":"4","author":"V V\u00f5ikar","year":"2005","unstructured":"V\u00f5ikar V, Polus A, Vasar E, Rauvala H (2005) Long-term individual housing in C57BL\/6J and DBA\/2 mice: assessment of behavioral consequences. Genes Brain Behav 4(4):240\u2013252. https:\/\/doi.org\/10.1111\/j.1601-183X.2004.00106.x","journal-title":"Genes Brain Behav"},{"key":"329_CR40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s12640-020-00227-8","volume":"38","author":"J Wojcieszak","year":"2020","unstructured":"Wojcieszak J, Kuczy\u0144ska K, Zawilska JB (2020) Four synthetic cathinones: 3-chloromethcathinone, 4-chloromethcathinone, 4-fluoro-\u03b1-pyrrolidinopentiophenone, and 4-methoxy-\u03b1-pyrrolidinopentiophenone produce changes in the spontaneous locomotor activity and motor performance in mice with varied profiles. Neurotox Res 38:536\u2013551. https:\/\/doi.org\/10.1007\/s12640-020-00227-8","journal-title":"Neurotox Res"},{"issue":"1\u20133","key":"329_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","volume":"231","author":"JB Zawilska","year":"2013","unstructured":"Zawilska JB, Wojcieszak J (2013) Designer cathinones\u2013an emerging class of novel recreational drugs. Forensic Sci Int 231(1\u20133):42\u201353. https:\/\/doi.org\/10.1016\/j.forsciint.2013.04.015","journal-title":"Forensic Sci Int"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00329-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00329-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00329-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T04:47:39Z","timestamp":1620103659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00329-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,11]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00329-x","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,11]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The use of adult male DBA\/2J inbred mice for the experiments was approved by the Local Ethical Commission for Experimentations on Animals in \u0141\u00f3d\u017a. This article does not contain any studies with human participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}